News and Announcements

In a word, “yes,” according to newly published work from UVA.

Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the NIH to determine if the powerful anesthetic ketamine can save patients from prolonged, life-threatening grand mal seizures that resist other treatments.

A new study led by Chia-Yi Kuan, MD, PhD, a professor in the Department of Neuroscience, revealed how microglia regulate the local blood flow responses to neural activity, a process called neurovascular coupling.

Dr. Anelyssa D’Abreu talked with UVA Today about ways people can reduce their risk of developing dementia, most often linked to Alzheimer’s disease.

Lulu Jiang, MD, PhD, an assistant professor in the Department of Neuroscience at UVA School of Medicine, was awarded a $3.6 million R01 grant from the National Institute on Aging for her project titled “Epitranscriptomic Mechanism in the Pathogenesis of Alzheimer’s Disease.” Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting over 6 million people […]

Michaela DuBay, an autism researcher at UVA, is leading several initiatives in Bolivia aimed at building stronger support networks for families of children with autism.

UVA researchers’ laboratory findings could be life-changing for those suffering from neurodegenerative diseases. Funding from UVA’s Brain Institute will help them take their research to the next level.